Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Cryoport, Inc.CYRX · Entity 5125 | Director · President, CEO | August 11, 2026 | August 11, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Cryoport, Inc.
Report date August 11, 2026 · Filed August 11, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 1,201,814 |
Reported balance
After 2026-08-11 transaction · row 1
1 source rowRow 1 · 2026-08-11 · Sale · Disposed 28,800 · Balance 1,201,814 F1: The transactions reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 11, 2026. The Rule 10b5-1 trading plan was terminated on August 11, 2026. F2: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.66 to $15.16, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Filing footnotes · ownership attribution and instrument terms
F1: The transactions reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 11, 2026. The Rule 10b5-1 trading plan was terminated on August 11, 2026.
F2: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.66 to $15.16, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 11, 2026 Filed Aug 11, 2026 22:49 UTC | Cryoport, Inc. CYRX · Entity 5125 | SaleCommon Stock | 28,800 | $14.91 | $429,384.96 |
DisclosureSEC source: 0001104659-26-094228 · tm2622922-1_4seq1.xml · nonDerivative · entry 1 SHELTON JERRELL · CIK 0001283212 · Director · President, CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,201,814 F1 · kind: The transactions reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 11, 2026. The Rule 10b5-1 trading plan was terminated on August 11, 2026. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.66 to $15.16, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 21, 2026 Filed Apr 24, 2026 00:00 UTC | Cryoport, Inc. CYRX · Entity 5125 | Exercise / conversionOptions to purchase common stock · Derivative | 104,007 | $0.00 Strike: $1.87 | $0.00 |
DisclosureSEC source: 0001104659-26-047945 · tm2612625-1_4seq1.xml · derivative · entry 2 SHELTON JERRELL · CIK 0001283212 · Director · President, CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 104,007 shares Expires 2026-05-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: 1/48 of options vested on the 6th of each month for forty-eight months beginning May 6, 2016. Read SEC document |
| April 21, 2026 Filed Apr 24, 2026 00:00 UTC | Cryoport, Inc. CYRX · Entity 5125 | Exercise / conversionCommon Stock | 104,007 | $1.87 | $194,493.09 |
DisclosureSEC source: 0001104659-26-047945 · tm2612625-1_4seq1.xml · nonDerivative · entry 1 SHELTON JERRELL · CIK 0001283212 · Director · President, CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,230,614 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 06, 2026 Filed Apr 8, 2026 22:32 UTC | Cryoport, Inc. CYRX · Entity 5125 | Exercise / conversionOptions to purchase common stock · Derivative | 50,000 | $0.00 Strike: $1.87 | $0.00 |
DisclosureSEC source: 0001104659-26-041041 · tm2611424-1_4seq1.xml · derivative · entry 2 SHELTON JERRELL · CIK 0001283212 · Director · President, CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 104,007 Underlying: Common Stock · 50,000 shares Expires 2026-05-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: 1/48 of options vested on the 6th of each month for forty-eight months beginning May 6, 2016. Read SEC document |
| April 06, 2026 Filed Apr 8, 2026 22:32 UTC | Cryoport, Inc. CYRX · Entity 5125 | Exercise / conversionCommon Stock | 50,000 | $1.87 | $93,500.00 |
DisclosureSEC source: 0001104659-26-041041 · tm2611424-1_4seq1.xml · nonDerivative · entry 1 SHELTON JERRELL · CIK 0001283212 · Director · President, CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,126,607 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 23, 2026 Filed Mar 26, 2026 00:00 UTC | Cryoport, Inc. CYRX · Entity 5125 | Exercise / conversionOptions to purchase common stock · Derivative | 25,000 | $0.00 Strike: $1.87 | $0.00 |
DisclosureSEC source: 0001104659-26-034753 · tm269766-2_4seq1.xml · derivative · entry 3 SHELTON JERRELL · CIK 0001283212 · Director · President, CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 154,007 Underlying: Common Stock · 25,000 shares Expires 2026-05-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 1/48 of options vested on the 6th of each month for forty-eight months beginning May 6, 2016. Read SEC document |
| March 23, 2026 Filed Mar 26, 2026 00:00 UTC | Cryoport, Inc. CYRX · Entity 5125 | Exercise / conversionCommon Stock | 25,000 | $1.87 | $46,750.00 |
DisclosureSEC source: 0001104659-26-034753 · tm269766-2_4seq1.xml · nonDerivative · entry 2 SHELTON JERRELL · CIK 0001283212 · Director · President, CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,076,607 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 23, 2026 Filed Mar 26, 2026 00:00 UTC | Cryoport, Inc. CYRX · Entity 5125 | SaleCommon Stock | 2,894 | $8.18 | $23,672.92 |
DisclosureSEC source: 0001104659-26-034753 · tm269766-2_4seq1.xml · nonDerivative · entry 1 SHELTON JERRELL · CIK 0001283212 · Director · President, CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,051,607 F1 · kind: Shares required to be sold in accordance with the Issuer's policies, in payment of taxes due upon the vesting of restricted stock rights. Read SEC document |
| March 16, 2026 Filed Mar 18, 2026 00:00 UTC | Cryoport, Inc. CYRX · Entity 5125 | SaleCommon Stock | 7,918 | $8.00 | $63,344.00 |
DisclosureSEC source: 0001104659-26-029719 · tm269014-3_4seq1.xml · nonDerivative · entry 1 SHELTON JERRELL · CIK 0001283212 · Director · President, CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,054,501 F1 · kind: Shares required to be sold in accordance with the Issuer's policies, in payment of taxes due upon the vesting of restricted stock rights. Read SEC document |
| March 14, 2026 Filed Mar 18, 2026 00:00 UTC | Cryoport, Inc. CYRX · Entity 5125 | GrantStock Option (right to buy) · Derivative | 492,901 | $0.00 Strike: $8.60 | $0.00 |
DisclosureSEC source: 0001104659-26-029719 · tm269014-3_4seq1.xml · derivative · entry 2 SHELTON JERRELL · CIK 0001283212 · Director · President, CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 492,901 Underlying: Common Stock · 492,901 shares Expires 2033-03-14 F2 · derivative.exercise_date: 1/48 of options vest on the 14th of each month for forty-eight months beginning April 14, 2026. Read SEC document |
| August 13, 2025 Filed Aug 15, 2025 21:00 UTC | Cryoport, Inc. CYRX · Entity 5125 | Exercise / conversionStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $5.00 | $0.00 |
DisclosureSEC source: 0001104659-25-079308 · tm2523591d1_4seq1.xml · derivative · entry 2 SHELTON JERRELL · CIK 0001283212 · Director · President, CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 25,000 shares Expires 2025-08-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: This transaction involved a cash exercise of a stock option without a subsequent sale of the underlying shares of common stock. F2 · derivative.exercise_date: 1/48 of the options vested on the 19th of each month for forty-eight months beginning on 8/19/2015. Read SEC document |
| August 13, 2025 Filed Aug 15, 2025 21:00 UTC | Cryoport, Inc. CYRX · Entity 5125 | Exercise / conversionCommon Stock | 25,000 | $5.00 | $125,000.00 |
DisclosureSEC source: 0001104659-25-079308 · tm2523591d1_4seq1.xml · nonDerivative · entry 1 SHELTON JERRELL · CIK 0001283212 · Director · President, CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,062,419 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: This transaction involved a cash exercise of a stock option without a subsequent sale of the underlying shares of common stock. Read SEC document |
| July 31, 2025 Filed Aug 4, 2025 22:00 UTC | Cryoport, Inc. CYRX · Entity 5125 | Exercise / conversionStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $5.00 | $0.00 |
DisclosureSEC source: 0001104659-25-073737 · tm2522494-1_4seq1.xml · derivative · entry 2 SHELTON JERRELL · CIK 0001283212 · Director · President, CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2025-08-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: This transaction involved a cash exercise of a stock option without a subsequent sale of the underlying shares of common stock. F2 · derivative.exercise_date: 1/48 of the options vested on the 19th of each month for forty-eight months beginning on 8/19/2015. Read SEC document |
| July 31, 2025 Filed Aug 4, 2025 22:00 UTC | Cryoport, Inc. CYRX · Entity 5125 | Exercise / conversionCommon Stock | 25,000 | $5.00 | $125,000.00 |
DisclosureSEC source: 0001104659-25-073737 · tm2522494-1_4seq1.xml · nonDerivative · entry 1 SHELTON JERRELL · CIK 0001283212 · Director · President, CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,037,419 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: This transaction involved a cash exercise of a stock option without a subsequent sale of the underlying shares of common stock. Read SEC document |
| July 24, 2025 Filed Jul 28, 2025 21:04 UTC | Cryoport, Inc. CYRX · Entity 5125 | Exercise / conversionStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $5.00 | $0.00 |
DisclosureSEC source: 0001104659-25-071212 · tm2521880-1_4seq1.xml · derivative · entry 2 SHELTON JERRELL · CIK 0001283212 · Director · President, CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 25,000 shares Expires 2025-08-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: This transaction involved a cash exercise of a stock option without a subsequent sale of the underlying shares of common stock. F2 · derivative.exercise_date: 1/48 of the options vested on the 19th of each month for forty-eight months beginning on 8/19/2015. Read SEC document |
| July 24, 2025 Filed Jul 28, 2025 21:04 UTC | Cryoport, Inc. CYRX · Entity 5125 | Exercise / conversionCommon Stock | 25,000 | $5.00 | $125,000.00 |
DisclosureSEC source: 0001104659-25-071212 · tm2521880-1_4seq1.xml · nonDerivative · entry 1 SHELTON JERRELL · CIK 0001283212 · Director · President, CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,012,419 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: This transaction involved a cash exercise of a stock option without a subsequent sale of the underlying shares of common stock. Read SEC document |
| July 18, 2025 Filed Jul 22, 2025 20:52 UTC | Cryoport, Inc. CYRX · Entity 5125 | Exercise / conversionStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $5.00 | $0.00 |
DisclosureSEC source: 0001104659-25-069643 · tm2521375-1_4seq1.xml · derivative · entry 2 SHELTON JERRELL · CIK 0001283212 · Director · President, CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 25,000 shares Expires 2025-08-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: This transaction involved a cash exercise of a stock option without a subsequent sale of the underlying shares of common stock. F2 · derivative.exercise_date: 1/48 of the options vested on the 19th of each month for forty-eight months beginning on 8/19/2015. Read SEC document |
| July 18, 2025 Filed Jul 22, 2025 20:52 UTC | Cryoport, Inc. CYRX · Entity 5125 | Exercise / conversionCommon Stock | 25,000 | $5.00 | $125,000.00 |
DisclosureSEC source: 0001104659-25-069643 · tm2521375-1_4seq1.xml · nonDerivative · entry 1 SHELTON JERRELL · CIK 0001283212 · Director · President, CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 987,419 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: This transaction involved a cash exercise of a stock option without a subsequent sale of the underlying shares of common stock. Read SEC document |
| July 08, 2025 Filed Jul 10, 2025 21:00 UTC | Cryoport, Inc. CYRX · Entity 5125 | Exercise / conversionStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $5.00 | $0.00 |
DisclosureSEC source: 0001104659-25-067025 · tm2520208-1_4seq1.xml · derivative · entry 2 SHELTON JERRELL · CIK 0001283212 · Director · President, CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 25,000 shares Expires 2025-08-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: This transaction involved a cash exercise of a stock option without a subsequent sale of the underlying shares of common stock. F2 · derivative.exercise_date: 1/48 of the options vested on the 19th of each month for forty-eight months beginning on 8/19/2015. Read SEC document |
| July 08, 2025 Filed Jul 10, 2025 21:00 UTC | Cryoport, Inc. CYRX · Entity 5125 | Exercise / conversionCommon Stock | 25,000 | $5.00 | $125,000.00 |
DisclosureSEC source: 0001104659-25-067025 · tm2520208-1_4seq1.xml · nonDerivative · entry 1 SHELTON JERRELL · CIK 0001283212 · Director · President, CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 962,419 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: This transaction involved a cash exercise of a stock option without a subsequent sale of the underlying shares of common stock. Read SEC document |
| June 25, 2025 Filed Jun 27, 2025 00:00 UTC | Cryoport, Inc. CYRX · Entity 5125 | Exercise / conversionStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $5.00 | $0.00 |
DisclosureSEC source: 0001104659-25-063166 · tm2519235-2_4seq1.xml · derivative · entry 5 SHELTON JERRELL · CIK 0001283212 · Director · President, CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 125,000 Underlying: Common Stock · 25,000 shares Expires 2025-08-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: This transaction involved a cash exercise of a stock option without a subsequent sale of the underlying shares of common stock. F4 · derivative.exercise_date: 1/48 of the options vested on the 19th of each month for forty-eight months beginning on 8/19/2015. Read SEC document |
| June 25, 2025 Filed Jun 27, 2025 00:00 UTC | Cryoport, Inc. CYRX · Entity 5125 | Exercise / conversionCommon Stock | 25,000 | $5.00 | $125,000.00 |
DisclosureSEC source: 0001104659-25-063166 · tm2519235-2_4seq1.xml · nonDerivative · entry 3 SHELTON JERRELL · CIK 0001283212 · Director · President, CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 937,419 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: This transaction involved a cash exercise of a stock option without a subsequent sale of the underlying shares of common stock. Read SEC document |
| June 24, 2025 Filed Jun 27, 2025 00:00 UTC | Cryoport, Inc. CYRX · Entity 5125 | Exercise / conversionStock Option (right to buy) · Derivative | 16,344 | $0.00 Strike: $5.00 | $0.00 |
DisclosureSEC source: 0001104659-25-063166 · tm2519235-2_4seq1.xml · derivative · entry 4 SHELTON JERRELL · CIK 0001283212 · Director · President, CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Stock · 16,344 shares Expires 2025-08-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: This transaction occurred automatically pursuant to a trading plan adopted by the reporting person on June 3, 2025. F4 · derivative.exercise_date: 1/48 of the options vested on the 19th of each month for forty-eight months beginning on 8/19/2015. Read SEC document |
| June 24, 2025 Filed Jun 27, 2025 00:00 UTC | Cryoport, Inc. CYRX · Entity 5125 | SaleCommon Stock | 16,344 | $7.06 | $115,365.76 |
DisclosureSEC source: 0001104659-25-063166 · tm2519235-2_4seq1.xml · nonDerivative · entry 2 SHELTON JERRELL · CIK 0001283212 · Director · President, CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 912,419 F1 · shares: This transaction occurred automatically pursuant to a trading plan adopted by the reporting person on June 3, 2025. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.61 to $7.31, inclusive. Read SEC document |
| June 24, 2025 Filed Jun 27, 2025 00:00 UTC | Cryoport, Inc. CYRX · Entity 5125 | Exercise / conversionCommon Stock | 16,344 | $5.00 | $81,720.00 |
DisclosureSEC source: 0001104659-25-063166 · tm2519235-2_4seq1.xml · nonDerivative · entry 1 SHELTON JERRELL · CIK 0001283212 · Director · President, CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 928,763 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: This transaction occurred automatically pursuant to a trading plan adopted by the reporting person on June 3, 2025. Read SEC document |
| June 20, 2025 Filed Jun 21, 2025 00:15 UTC | Cryoport, Inc. CYRX · Entity 5125 | Exercise / conversionStock Option (right to buy) · Derivative | 69,135 | $0.00 Strike: $5.00 | $0.00 |
DisclosureSEC source: 0001104659-25-061279 · tm2518590-1_4seq1.xml · derivative · entry 11 SHELTON JERRELL · CIK 0001283212 · Director · President, CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 166,344 Underlying: Common Stock · 69,135 shares Expires 2025-08-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: This transaction occurred automatically pursuant to a trading plan adopted by the reporting person on June 3, 2025. F6 · derivative.exercise_date: 1/48 of the options vested on the 19th of each month for forty-eight months beginning on 8/19/2015. Read SEC document |
| June 20, 2025 Filed Jun 21, 2025 00:15 UTC | Cryoport, Inc. CYRX · Entity 5125 | SaleCommon Stock | 69,135 | $6.47 | $447,524.68 |
DisclosureSEC source: 0001104659-25-061279 · tm2518590-1_4seq1.xml · nonDerivative · entry 7 SHELTON JERRELL · CIK 0001283212 · Director · President, CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 912,419 F2 · shares: This transaction occurred automatically pursuant to a trading plan adopted by the reporting person on June 3, 2025. F5 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.33 to $6.83, inclusive. Read SEC document |
| June 20, 2025 Filed Jun 21, 2025 00:15 UTC | Cryoport, Inc. CYRX · Entity 5125 | Exercise / conversionCommon Stock | 69,135 | $5.00 | $345,675.00 |
DisclosureSEC source: 0001104659-25-061279 · tm2518590-1_4seq1.xml · nonDerivative · entry 6 SHELTON JERRELL · CIK 0001283212 · Director · President, CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 981,554 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: This transaction occurred automatically pursuant to a trading plan adopted by the reporting person on June 3, 2025. Read SEC document |
| June 18, 2025 Filed Jun 21, 2025 00:15 UTC | Cryoport, Inc. CYRX · Entity 5125 | Exercise / conversionStock Option (right to buy) · Derivative | 119,281 | $0.00 Strike: $5.00 | $0.00 |
DisclosureSEC source: 0001104659-25-061279 · tm2518590-1_4seq1.xml · derivative · entry 10 SHELTON JERRELL · CIK 0001283212 · Director · President, CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 235,479 Underlying: Common Stock · 119,281 shares Expires 2025-08-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: This transaction occurred automatically pursuant to a trading plan adopted by the reporting person on June 3, 2025. F6 · derivative.exercise_date: 1/48 of the options vested on the 19th of each month for forty-eight months beginning on 8/19/2015. Read SEC document |
| June 18, 2025 Filed Jun 21, 2025 00:15 UTC | Cryoport, Inc. CYRX · Entity 5125 | SaleCommon Stock | 119,281 | $6.81 | $812,542.17 |
DisclosureSEC source: 0001104659-25-061279 · tm2518590-1_4seq1.xml · nonDerivative · entry 5 SHELTON JERRELL · CIK 0001283212 · Director · President, CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 912,419 F2 · shares: This transaction occurred automatically pursuant to a trading plan adopted by the reporting person on June 3, 2025. F4 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.62 to $6.97, inclusive. Read SEC document |
| June 18, 2025 Filed Jun 21, 2025 00:15 UTC | Cryoport, Inc. CYRX · Entity 5125 | Exercise / conversionCommon Stock | 119,281 | $5.00 | $596,405.00 |
DisclosureSEC source: 0001104659-25-061279 · tm2518590-1_4seq1.xml · nonDerivative · entry 4 SHELTON JERRELL · CIK 0001283212 · Director · President, CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,031,700 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: This transaction occurred automatically pursuant to a trading plan adopted by the reporting person on June 3, 2025. Read SEC document |
| June 17, 2025 Filed Jun 21, 2025 00:15 UTC | Cryoport, Inc. CYRX · Entity 5125 | Exercise / conversionStock Option (right to buy) · Derivative | 151,304 | $0.00 Strike: $5.00 | $0.00 |
DisclosureSEC source: 0001104659-25-061279 · tm2518590-1_4seq1.xml · derivative · entry 9 SHELTON JERRELL · CIK 0001283212 · Director · President, CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 354,760 Underlying: Common Stock · 151,304 shares Expires 2025-08-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: This transaction occurred automatically pursuant to a trading plan adopted by the reporting person on June 3, 2025. F6 · derivative.exercise_date: 1/48 of the options vested on the 19th of each month for forty-eight months beginning on 8/19/2015. Read SEC document |
| June 17, 2025 Filed Jun 21, 2025 00:15 UTC | Cryoport, Inc. CYRX · Entity 5125 | Exercise / conversionStock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $5.00 | $0.00 |
DisclosureSEC source: 0001104659-25-061279 · tm2518590-1_4seq1.xml · derivative · entry 8 SHELTON JERRELL · CIK 0001283212 · Director · President, CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 506,064 Underlying: Common Stock · 50,000 shares Expires 2025-08-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: This transaction involved a cash exercise of a stock option without a subsequent sale of the underlying shares of common stock. F6 · derivative.exercise_date: 1/48 of the options vested on the 19th of each month for forty-eight months beginning on 8/19/2015. Read SEC document |
| June 17, 2025 Filed Jun 21, 2025 00:15 UTC | Cryoport, Inc. CYRX · Entity 5125 | SaleCommon Stock | 151,304 | $6.81 | $1,029,714.50 |
DisclosureSEC source: 0001104659-25-061279 · tm2518590-1_4seq1.xml · nonDerivative · entry 3 SHELTON JERRELL · CIK 0001283212 · Director · President, CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 912,419 F2 · shares: This transaction occurred automatically pursuant to a trading plan adopted by the reporting person on June 3, 2025. F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.57 to $6.96, inclusive. Read SEC document |
| June 17, 2025 Filed Jun 21, 2025 00:15 UTC | Cryoport, Inc. CYRX · Entity 5125 | Exercise / conversionCommon Stock | 151,304 | $5.00 | $756,520.00 |
DisclosureSEC source: 0001104659-25-061279 · tm2518590-1_4seq1.xml · nonDerivative · entry 2 SHELTON JERRELL · CIK 0001283212 · Director · President, CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,063,723 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: This transaction occurred automatically pursuant to a trading plan adopted by the reporting person on June 3, 2025. Read SEC document |
| June 17, 2025 Filed Jun 21, 2025 00:15 UTC | Cryoport, Inc. CYRX · Entity 5125 | Exercise / conversionCommon Stock | 50,000 | $5.00 | $250,000.00 |
DisclosureSEC source: 0001104659-25-061279 · tm2518590-1_4seq1.xml · nonDerivative · entry 1 SHELTON JERRELL · CIK 0001283212 · Director · President, CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 912,419 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: This transaction involved a cash exercise of a stock option without a subsequent sale of the underlying shares of common stock. Read SEC document |
| June 04, 2025 Filed Jun 6, 2025 18:21 UTC | Cryoport, Inc. CYRX · Entity 5125 | Exercise / conversionStock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $5.00 | $0.00 |
DisclosureSEC source: 0001104659-25-057218 · tm2517352-1_4seq1.xml · derivative · entry 2 SHELTON JERRELL · CIK 0001283212 · Director · President, CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 556,064 Underlying: COMMON STOCK · 50,000 shares Expires 2025-11-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: This transaction involved a cash exercise of a stock option without a subsequent sale of the underlying shares of common stock. F2 · derivative.exercise_date: 1/48 of the options vested on the 19th of each month for forty-eight months beginning on 8/19/2015. Read SEC document |
| June 04, 2025 Filed Jun 6, 2025 18:21 UTC | Cryoport, Inc. CYRX · Entity 5125 | Exercise / conversionCommon Stock | 50,000 | $5.00 | $250,000.00 |
DisclosureSEC source: 0001104659-25-057218 · tm2517352-1_4seq1.xml · nonDerivative · entry 1 SHELTON JERRELL · CIK 0001283212 · Director · President, CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 862,419 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: This transaction involved a cash exercise of a stock option without a subsequent sale of the underlying shares of common stock. Read SEC document |
| June 02, 2025 Filed Jun 4, 2025 01:25 UTC Amendment | Cryoport, Inc. CYRX · Entity 5125 | Exercise / conversionCommon Stock | 50,000 | $5.00 | $250,000.00 |
DisclosureSEC source: 0001104659-25-056133 · tm2517104-1_4aseq1.xml · nonDerivative · entry 1 SHELTON JERRELL · CIK 0001283212 · Director · President, CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 812,419 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 02, 2025 Filed Jun 3, 2025 20:04 UTC | Cryoport, Inc. CYRX · Entity 5125 | Exercise / conversionStock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $5.00 | $0.00 |
DisclosureSEC source: 0001104659-25-055953 · tm2517027-1_4seq1.xml · derivative · entry 2 SHELTON JERRELL · CIK 0001283212 · Director · President, CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 606,064 Underlying: COMMON STOCK · 50,000 shares Expires 2025-11-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: 1/48 of the options vested on the 19th of each month for forty-eight months beginning on 8/19/2015. Read SEC document |
| June 02, 2025 Filed Jun 3, 2025 20:04 UTC | Cryoport, Inc. CYRX · Entity 5125 | Exercise / conversionCommon Stock | 50,000 | $5.00 | $250,000.00 |
DisclosureSEC source: 0001104659-25-055953 · tm2517027-1_4seq1.xml · nonDerivative · entry 1 SHELTON JERRELL · CIK 0001283212 · Director · President, CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 812,419 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 24, 2025 Filed Mar 26, 2025 23:00 UTC | Cryoport, Inc. CYRX · Entity 5125 | SaleCommon Stock | 2,980 | $6.94 | $20,685.97 |
DisclosureSEC source: 0001104659-25-028320 · tm2510559-1_4seq1.xml · nonDerivative · entry 1 SHELTON JERRELL · CIK 0001283212 · Director · President, CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 762,419 F1 · kind: Shares required to be sold in accordance with the Issuer's policies, in payment of taxes due upon the vesting of restricted stock rights Read SEC document |
| March 17, 2025 Filed Mar 18, 2025 23:05 UTC | Cryoport, Inc. CYRX · Entity 5125 | SaleCommon Stock | 4,620 | $6.29 | $29,067.65 |
DisclosureSEC source: 0001104659-25-025192 · tm259699-1_4seq1.xml · nonDerivative · entry 2 SHELTON JERRELL · CIK 0001283212 · Director · President, CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 765,399 F2 · kind: Shares required to be sold in accordance with the Issuer's policies, in payment of taxes due upon the vesting of restricted stock rights. Read SEC document |
| March 14, 2025 Filed Mar 18, 2025 23:05 UTC | Cryoport, Inc. CYRX · Entity 5125 | GrantStock Option (right to buy) · Derivative | 75,000 | $0.00 Strike: $7.05 | $0.00 |
DisclosureSEC source: 0001104659-25-025192 · tm259699-1_4seq1.xml · derivative · entry 3 SHELTON JERRELL · CIK 0001283212 · Director · President, CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2032-03-14 F3 · derivative.exercise_date: 1/48 of options vest on the 14th of each month for forty-eight months beginning April 14, 2025. Read SEC document |
| March 14, 2025 Filed Mar 18, 2025 23:05 UTC | Cryoport, Inc. CYRX · Entity 5125 | GrantCommon Stock | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-025192 · tm259699-1_4seq1.xml · nonDerivative · entry 1 SHELTON JERRELL · CIK 0001283212 · Director · President, CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 770,019 F1 · security: Represents restricted stock rights, which are a contingent right to receive one share of CYRX common stock, that vest in four equal annual installments beginning March 14, 2026. F1 · price: Represents restricted stock rights, which are a contingent right to receive one share of CYRX common stock, that vest in four equal annual installments beginning March 14, 2026. Read SEC document |
| March 10, 2025 Filed Mar 11, 2025 23:01 UTC | Cryoport, Inc. CYRX · Entity 5125 | SaleCommon Stock | 4,173 | $4.88 | $20,360.48 |
DisclosureSEC source: 0001104659-25-022643 · tm258882-2_4seq1.xml · nonDerivative · entry 2 SHELTON JERRELL · CIK 0001283212 · Director · President, CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 740,019 F2 · kind: Shares required to be sold in accordance with the Issuer's policies, in payment of taxes due upon the vesting of restricted stock rights. Read SEC document |
| March 09, 2025 Filed Mar 11, 2025 23:01 UTC | Cryoport, Inc. CYRX · Entity 5125 | Exercise / conversionRestricted Stock Rights · Derivative | 8,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-022643 · tm258882-2_4seq1.xml · derivative · entry 3 SHELTON JERRELL · CIK 0001283212 · Director · President, CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,250 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: The originally granted restricted stock rights vest in four equal annual installments beginning March 9, 2022, and have no expiration date. The restricted stock rights reported herein vested and converted to shares of CYRX common stock on a one-for-one basis on March 9, 2025. F1 · kind: Represents the conversion of restricted stock rights to shares of common stock upon vesting. Each restricted stock right represents a contingent right to receive one share of CYRX common stock. F3 · derivative.exercise_date: The originally granted restricted stock rights vest in four equal annual installments beginning March 9, 2022, and have no expiration date. The restricted stock rights reported herein vested and converted to shares of CYRX common stock on a one-for-one basis on March 9, 2025. F3 · derivative.expiration_date: The originally granted restricted stock rights vest in four equal annual installments beginning March 9, 2022, and have no expiration date. The restricted stock rights reported herein vested and converted to shares of CYRX common stock on a one-for-one basis on March 9, 2025. Read SEC document |
| March 09, 2025 Filed Mar 11, 2025 23:01 UTC | Cryoport, Inc. CYRX · Entity 5125 | Exercise / conversionCommon Stock | 8,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-022643 · tm258882-2_4seq1.xml · nonDerivative · entry 1 SHELTON JERRELL · CIK 0001283212 · Director · President, CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 744,192 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents the conversion of restricted stock rights to shares of common stock upon vesting. Each restricted stock right represents a contingent right to receive one share of CYRX common stock. F1 · price: Represents the conversion of restricted stock rights to shares of common stock upon vesting. Each restricted stock right represents a contingent right to receive one share of CYRX common stock. Read SEC document |
| November 22, 2024 Filed Nov 26, 2024 00:00 UTC | Cryoport, Inc. CYRX · Entity 5125 | Exercise / conversionStock Option (right to buy) · Derivative | 26,862 | $0.00 Strike: $4.80 | $0.00 |
DisclosureSEC source: 0001104659-24-122676 · tm2429442-1_4seq1.xml · derivative · entry 6 SHELTON JERRELL · CIK 0001283212 · Director · President, CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 26,862 shares Expires 2024-12-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2024. F4 · derivative.exercise_date: 1/48 of the options vested on the 18th of each month for forty-eight months beginning on January 18, 2015. Read SEC document |
| November 22, 2024 Filed Nov 26, 2024 00:00 UTC | Cryoport, Inc. CYRX · Entity 5125 | SaleCommon Stock | 22,817 | $6.47 | $147,612.30 |
DisclosureSEC source: 0001104659-24-122676 · tm2429442-1_4seq1.xml · nonDerivative · entry 4 SHELTON JERRELL · CIK 0001283212 · Director · President, CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 735,942 F1 · kind: The transactions reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2024. F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.34 to $6.60, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.